Lv31
380 积分 2023-03-26 加入
Patient-Focused Drug Development
2小时前
待确认
Potent antitumor activity of ensartinib in MET exon 14 skipping-mutated non-small cell lung cancer
3个月前
已完结
Exertional Heat Stroke: Pathophysiology, Epidemiology, Diagnosis, Treatment, and Prevention
5个月前
已关闭
Three ways ChatGPT helps me in my academic writing
6个月前
已完结
The landscape of T cell antigens for cancer immunotherapy
8个月前
已完结
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
8个月前
已完结
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
1年前
已关闭
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
1年前
已完结
MET alterations in NSCLC—Current Perspectives and Future Challenges
1年前
已完结
D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients With NSCLC: Phase 1 Study Results
1年前
已完结
皖公网安备34019202002308
